Profile
Teresa M.
Foy worked as Director-Preclinical Biology at Corixa Corp.
Worked as Director-Preclinical Development at GlaxoSmithKline Biologicals SA. Served as Independent Director at NS Wind Down Co., Inc. from 2022 to 2024.
Served as Chief Scientific Officer at Oncofactor Corp.
Served as Senior Vice President-Research & Development at Viral Logic Systems Technology Corp.
from 2010 to 2012.
Served as Senior VP-Immuno Oncology & Cell Therapy at Bristol Myers Squibb Co. from 2019 to 2025.
Education includes graduate degree from St. Cloud State University, doctorate from the University of Iowa, and undergraduate degree from the University of Minnesota.
Former positions of Teresa Foy
| Companies | Position | End |
|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01/03/2025 |
| NS WIND DOWN CO., INC. | Director/Board Member | 26/06/2024 |
Oncofactor Corp.
Oncofactor Corp. Pharmaceuticals: MajorHealth Technology Develops antibody drugs against new biologic targets in cancer | Chief Tech/Sci/R&D Officer | - |
Corixa Corp.
Corixa Corp. BiotechnologyHealth Technology Develops and manufactures oncology and immunology products | Corporate Officer/Principal | - |
GlaxoSmithKline Biologicals SA
GlaxoSmithKline Biologicals SA BiotechnologyHealth Technology Operates biopharma and pharmaceutical company | Corporate Officer/Principal | - |
Training of Teresa Foy
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
Bristol Myers Squibb Co.
Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Corixa Corp.
Corixa Corp. BiotechnologyHealth Technology Develops and manufactures oncology and immunology products | Health Technology |
Oncofactor Corp.
Oncofactor Corp. Pharmaceuticals: MajorHealth Technology Develops antibody drugs against new biologic targets in cancer | Health Technology |
GlaxoSmithKline Biologicals SA
GlaxoSmithKline Biologicals SA BiotechnologyHealth Technology Operates biopharma and pharmaceutical company | Health Technology |
St. Cloud State University
St. Cloud State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Iowa
University of Iowa Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Minnesota
University of Minnesota Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NS Wind Down Co., Inc.
NS Wind Down Co., Inc. Medical SpecialtiesHealth Technology Develops and manufactures life science tools for translational research and molecular diagnostic products | Health Technology |
Viral Logic Systems Technology Corp.
Viral Logic Systems Technology Corp. Pharmaceuticals: MajorHealth Technology Develops therapeutics for autoimmune and inflammatory disorders | Health Technology |
- Stock Market
- Insiders
- Teresa Foy
















